Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 675-683

  Olale, Felix ^a   Gerzanich, Volodymyr ^b   Kuryatov, Alexander ^b   Wang, Fan ^b   Lindstrom, Jon ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; AUTONOMIC GANGLION; DRUG EXPOSURE; DRUG TOLERANCE; ELECTROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SMOKING; XENOPUS LAEVIS;

ANIMALS; DRUG TOLERANCE; FEMALE; HUMANS; NICOTINE; RECEPTORS, NICOTINIC; XENOPUS LAEVIS;

EID: 0030733496     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. AKAIKE, A., TAMURA, Y., YOKOTA, T., SHIMOHAMA, S. AND KJMURA, J.: Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644: 181-187, 1994.
2. ALKONDON, M. AND ALBUQUERQUE, E. X.: Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265: 1455-1473, 1993.
3. ANAND, K., CONROY, W. SCHOEPFER, R., WHITING, P. AND LINDSTROM, J: Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266: 11192-11198, 1991.
4. ANAND, R., PENG, X., BALLESTA, J. AND LINDSTROM, J.: Pharmacological characterization of α-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: Contrasting properties of α7 and α8 subunit-containing subtypes. Mol. Pharmacol. 44: 1046-50, 1993.
5. BENOWITZ, N.: Pharmacology of nicotine: Addiction and therapeutics. Annu. Rev. Pharmacol. Toxicol. 36: 597-613, 1996.
6. BENOWITZ, N., PORCHET, H. AND JACOB, P.: Pharmacokinetics, metabolism and pharmacodynamics of nicotine. In Nicotine Psychopharmacology, ed. by S. Wonnacott, M. Russell and I. Stolerman, pp. 112-157, Oxford Science Publications, Oxford, England, 1990.
7. BUISSON, B., GOPALAKRISHNAN, M., ARNERIC, S., SULLIVAN, J. AND BERTRAND, D.: Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch clamp study. J. Neurosci. 16: 7880-7891, 1996.
8. CIMINO, M., MARINI, P., FORNASARI, D., CATTEBENI, F. AND CLEMENTI, F.: Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of α3 subunit mRNA, α-bungarotoxin and nicotine binding sites. Neurosci. 51: 77-86, 1992.
9. COLLINS, A. AND MARKS, M.: Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev. Res. 38: 231-242, 1996.
10. CONROY, B. AND BERG, D.: Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem. 270: 4424-4431, 1995.
11. COUTURIER, S., BERTRAND, D., MATTER, J., HERNANDEZ, M., BERTRAND, S., MILLAR, N., VALERA, S., BARKAS, T. AND BALLIVET, M.: A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homooligomeric channel blocked by α-BTX. Neuron 5: 847-856, 1990.
12. DANI, J. AND HEINEMANN, S.: Molecular and cellular aspects of nicotine abuse. Neuron 16: 905-908, 1996.
13. DEL TORO, E., JUIZ, J., PENG, X., LINDSTROM, J. AND CRIADO, M.: Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in rat central nervous system. J. Comp. Neurol. 349: 325-342, 1994.
14. DURSUN, S., REVELEY, M., BIRD, R., STIRTON, F.: Long-lasting improvement of Tourette's syndrome with transdermal nicotine, Lancet 344: 1577, 1994.
15. FLORES, C., ROGERS, S., PABREZA, L., WOLFE, B. AND KELLAR, K.: A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 41: 31-37, 1992.
16. FREEDMAN, R., COON, H., MYLES-WORSLEY, M., ORR-URTREGER, A., OLINCY, A., DAVIS, ET AL.: Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA 94: 587-592, 1997.
17. GERZANICH, V., ANAND, R. AND LINDSTROM, J.: Homomers of α8 and α7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 45: 212-220, 1994.
18. GERZANICH, V., KURYATOV, A., ANAND, R. AND LINDSTROM, J.: "Orphan" α6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol. Pharmacol. 51: 320-327, 1997.
19. GERZANICH, V., PENG, X., WANG, F., WELLS, G., ANAND, R., FLETCHER, S. AND LINDSTROM, J.: Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48: 774-782, 1995.
20. GOPALAKRISHNAN, M., BUISSON, B., TOUMA, E., GIORDANO, T., CAMPBELL, J., HU, J., DONNELLY-ROBERTS, D., ARNERIC, S., BERTRAND, D. AND SULLIVAN, J.: Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor. Eur. J. Pharmacol. 290: 237-246, 1995.
21. GOPALAKRISHNAN, M., MONTEGGIA, L., ANDERSON, D., MOLINARI, E., PIATTONI-KAPLAN, M., DONNELLY-ROBERTS, D., ARNERIC, S. AND SULLIVAN, J.: Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J. Pharm. Exp. Ther. 276: 289-297, 1996.
22. GRAY, R., RAJAN, A., RADCLIFFE, K., YAKEHIRO, M. AND DANI, J.: Hippocampal synaptic transmission enhanced by low concentration of nicotine. Nature 383: 713-716, 1996.
23. HULIHAN-GIBLIN, B. LUMPKIN, M. AND KELLAR, K.: Acute effects of nicotine on prolactin release in the rat: Agonist and antagonist effects of a single injection of nicotine. J. Pharmacol. Exp. Ther. 252: 15-20, 1990a.
24. HULIHAN-GIBLIN, B., LUMPKIN, M. AND KELLAR, K.: Effects of chronic administration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. J. Pharmacol. Exp. Ther. 252: 21-25, 1990b.
25. HSU, Y., AMIN, J., WEISS, D. AND WECKER, L.: Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66: 667-775, 1996a.
26. HSU, Y., EDWARDS, S. AND WECKER, L.: Sustained exposure increases phosphorylation of the α4 subunit of α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes by both cyclic AMP-dependent protein kinase and a tyrosine kinase. Society for Neuroscience (Abstract 603.12)1526, 1996b.
27. LANGE, K., WELLS, F., JENNER, P. AND MARSDEN, C.: Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J. Neurochem. 60: 197-203, 1993.
28. LENOVERE, N., ZOLI, M. AND CHANGEUX, J.-P.: Neuronal nicotinic receptor α6 mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neursci. 8: 2428-2439, 1996.
29. + + ions in nicotinic facilitation of GABA release in mouse thalamus. J. Neurosci. 17: 576-585, 1997.
30. LESTER, R. AND DANI, J.: Time-dependent changes in central nicotinic acetylcholine channel kinetics in excised patches. Neuropharmacology 33: 27-34, 1994.
31. LINDSTROM J.: Neuronal nicotinic acetylcholine receptors. In Ion Channels, ed. by T. Narahashi, pp. 377-450, Plenum Press, New York, 1996.
32. LUKAS, R. J.: Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pbeochromocytoma or the TE671/RD human clonal line. J. Neurochem. 56: 1134-1145, 1991.
33. LUKAS, R., NORMAN, S. AND LUCERO, L.: Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4: 1-12, 1993.
34. MCGEHEE, D. AND ROLE, L.: Physiological diversity of nicotinic acetylcholine receptors expressed in vertebrate neurons. Annu. Rev. Physiol. 57: 521-546, 1995.
35. MELTON, D., KREIG, P., REBAGLIATI, M., MANIATIS, T., ZINN, K. AND GREEN, M. R.: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12: 7035-7056, 1984.
36. MOLINARI, E., GOPALAKRISHNAN, M. AND SULLIVAN, J. P.: Upregulation of recombinant human neuronal nicotinic acetylcholine receptors by cholinergic channel ligands: A role for protein kinases (Abstract). Soc. Neurosci. 122: 1527, 1996.
37. MORENS, D., GRANDINETTI, A., REED, D., WHITE, L. AND ROSS, G.: Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 45: 1041-1051, 1995.
38. PAPKE, R.: The kinetic properties of neuronal nicotinic receptors: Genetic basis of functional diversity. Adv. Neurobiol. 41: 509-531, 1992.
39. PENG, X., GERZANICH, V., ANAND, R., WHITING, P. AND LINDSTROM, J.: Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46: 523-530, 1994.
40. PENG, X., GERZANICH, V., ANAND, R., WANG, F. AND LINDSTROM, J.: Chronic nicotine treatment up-regulates. α3 AChRs and α7 AChRs expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51: 776-784, 1997.
41. PENG, X., KATZ, M., GERZANICH, V., ANAND, R. AND LINDSTROM, J.: Human α7 acetylcholine receptor: Cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol. Pharmacol. 45: 546-554, 1993.
42. PICCIOTTO, M., ZOLI, M., LENA, C., BESSIS, A., LALLEMAND, Y., LENOVERE, N., VINCENT, P., PICH, E., BRULET, P. AND CHANGEUX, J.-P.: Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374: 65-67, 1995.
43. ORR-URTREGER, A., GOLDMER, F., PATRICK, J. AND BEAUDET, A.: Generation of mice deficient in the α7 neuronal nicotinic receptor gene by targeted recombination. Neuroscience Society Meeting Abstract 501: 6, 1996.
44. SCHOEPFER, R., CONROY, W. G., WHITING, P., GORE, M. AND LINDSTROM, J.: Brain α-bungarotoxin binding protein cDNAs and mAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5: 35-48, 1990.
45. SEGUELA, P., WADICHE, J., DINELEY-MILLER, K., DANI, J. AND PATRICK, J.: Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13: 596-604, 1993.
46. SHARP, B. AND BEYER, S.: Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J. Pharmacol. Exp. Ther. 238: 486-491, 1986.
47. WADA, E., WADA, K., BOULTER, J., DENERIS, E., HEINEMANN, S., PATRICK, J. AND SWANSON, L. W.: Distribution of α2,α3, α4, and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous systems: a hybridization histochemical study in the rat. J. Comp. Neurol. 284: 314-335, 1989.
48. WANG, F., GERZANICH, V., WELLS, G., ANAND, R., PENG, X., KEYSER, K. AND LINDSTROM, J.: Assembly of the human neuronal nicotinic receptor α3 subunit with β2, β4, and α5 subunits. J. Biol. Chem. 271: 17656-17665, 1096.
49. WHITEHOUSE, P. J., MARTINO, A. M., MARCUS, K. A., ZWEIG, R. M., SINGER, H. S., PRICE, D. L. AND KELLAR, K. J.: Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch. Neurol 45: 722-724, 1988.
50. WHITING, P., SCHOEPFER, R., CONROY, W., GORE, M., KEYSER, K., SHIMASAKI, S., ESCH, F. AND LINDSTROM, J.: Expression of nicotinic AChR subtypes in brain and retina. Mol. Brain Res. 10: 61-70, 1991.
51. WONNACOTT, S., SOLIAKOV, L., WILKE, G., REDFERN, P. AND MARSHALL, D.: Presynaptic nicotinic acetylcholine receptors in the brain. Drug Dev Res 38: 149-159, 1996.
52. ZHANG, Z., COGGAN, J. AND BERG, D.: Synaptic currents generated by neuronal acetylcholine receptors sensitive to α-bungarotoxin Neuron 17: 1231-1240, 1996.